Malignant Potential of Positive Peritoneal Cytology in Endometrial Cancer

Obstetrics and Gynecology

Volumn 97, Issue 5, 2001, Pages 725-728

  Hirai, Yasuo ^a   Takeshima, Nobuhiro ^a   Kato, Tomoyasu ^a   Hasumi, Katsuhiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASCITES FLUID; CANCER STAGING; CELL TRANSFORMATION; CLINICAL TRIAL; ENDOMETRIUM TUMOR; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; METASTASIS; MIDDLE AGED; PATHOLOGY; PERITONEAL CAVITY; PERITONEUM LAVAGE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; ASCITIC FLUID; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL CAVITY; PERITONEAL LAVAGE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0035348289     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200105000-00016     Document Type: Article

References (17)

1. Creasman WT, Disaia PJ, Blessing J, Wilkinson RH, Johnston W, Weed JC. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981;141:921-9.
2. Mazurka JL, Krepart GV, Lotocki RJ. Prognostic significance of positive peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol 1988;158:303-6.
3. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74:775-80.
4. Kashimura M, Sugihara K, Toki N, Matsuura Y, Kawagoe T, Kamura T, et al. The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 1997;67:285-90.
5. Yazigi R, Piver SM, Blumenson L. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet Gynecol 1983;62:359-62.
6. Lurain JR, Rumsey NK, Schink JC, Wallemark CB, Chmiel JS. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1989;74:175-9.
7. Hirai Y, Fujimoto I, Yamauchi K, Hasumi K, Masubuchi K, Sano Y. Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma. Obstet Gynecol 1989;73:335-8.
8. Grimshaw RN, Tupper WC, Fraser RC, Tompkins MG, Jeffrey JF. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 1990;36:97-100.
9. Ebina Y, Hareyama N, Sakuragh N, Yamamoto R, Furuya M, Sogame M, et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg 1997;82:244-8.
10. Creasman WT, Lukeman J. Role of the fallopian tube in dissemination of malignant cells in corpus cancer. Cancer 1972;29:456-7.
11. Menczer J, Modan M, Goor E. The significance of positive tubal cytology in patients with endometrial carcinoma. Gynecol Oncol 1980;10:249-52.
12. Schmitz MJ, Nahhas WA. Hysteroscopy may transport malignant cells into the peritoneal cavity: Case report. Eur J Gynecol Oncol 1994;15:121-4.
13. Rose PG, Mendelsohn G, Kornbluth I. Hysteroscopic dissemination of endometrial carcinoma. Gynecol Oncol 1998;71:145-6.
14. Egarter C, Krestan C, Kurz C. Abdominal dissemination of malignant cells with hysteroscopy. Gynecol Oncol 1996;63:143-4.
15. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Does hysteroscopy facilitate tumor cell dissemination? Cancer 2000;88:139-43.
16. Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial cancer only if there is other evidence of extrauterine disease. Gynecol Oncol 1992;46:145-9.
17. Kadar N, Homesley HD, Malfetano JH. Prognostic factors in surgical stage III and IV carcinoma of the endometrium. Obstet Gynecol 1994;84:983-6.